The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January ...

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

The future of the Bay Area biotech firm Allakos was riding on one clinical trial, for a drug designed to treat the skin ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Out-licensing typically involves a drug discoverer and patent owner selling the rights to another pharmaceutical company for further investment in clinical trials to bring them for regulatory ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

A Waltham biotech is set to become the first Massachusetts company to go through with an initial public offering in 2025 this ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

H.C. Wainwright reaffirmed a Buy rating on Oncolytics Biotech (NASDAQ:ONCY) shares with a steady price target of $5.00. The stock, currently trading at $0.73 and near its 52-week low, shows potential ...

A Bay Area biotech is suing its insurance company to cover costs associated with patients allegedly injured during clinical ...